LYST and Alzheimer disease: UD-CHs were enriched in AD-LOY compared with AD-ROY patients (18/32, 56.2% versus 7/34, 20.6%, respectively; Fisher’s exact test, Benjamini-Hochberg-adjusted P = 0.038).